Admission procalcitonin measurements and microbiology results were available for 1040 hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International Severe Acute Respiratory and Emerging Infections Consortium World Health Organization Clinical Characterisation Protocol UK study). Although procalcitonin was higher in bacterial coinfection, this was neither clinically significant (median [IQR], 0.33 [0.11–1.70] ng/mL vs 0.24 [0.10–0.90] ng/mL) nor diagnostically useful (area under the receiver operating characteristic curve, 0.56 [95% confidence interval, .51–.60]).


This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite as

Relph, K., Russell, C., Fairfield, C., Turtle, L., de Silva, T., Siggins, M., Drake, T., Thwaites, R., Abrams, S., Moore, S., Hardwick, H., Oosthuyzen, W., Harrison, E., Docherty, A., Openshaw, P., Baillie, J., Semple, M., Ho, A. & ISARIC4C Investigators 2022, 'Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission', Open Forum Infectious Diseases, 9(5), article no: ofac179. https://doi.org/10.1093/ofid/ofac179

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 19 August 2023
Was this page helpful?